Commission chief Ursula von der Leyen is looking to build support among member states for overarching strategy to fill the gaps that exist at a national level in prevention, diagnosis, treatment and after care of cancer patients
Nobel prize-winning scientist Harald zur Hausen steps down as chair, citing personal reasons. He is replaced by Walter Ricciardi. Bettina Ryll, founder of a patients’ group that has transformed access to novel skin cancer treatments, joins the board
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.